REGDANVIMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Name

Type

Language

REGDANVIMAB

Official Name

English

Regdanvimab [WHO-DD]

Common Name

English

CTP-59

Code

English

CT-P59

Code

English

IMMUNOGLOBULIN G1, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL CT-P59 .GAMMA.-1 CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CT-P59 .LAMBDA.-CHAIN, DIMER

Common Name

English

regdanvimab [INN]

Common Name

English

CTP59

Code

English

Code System Code Type Description

FDA UNII

I0BGE6P6I6

Created by admin on Sat Dec 16 16:41:02 GMT 2023 , Edited by admin on Sat Dec 16 16:41:02 GMT 2023

PRIMARY

SMS_ID

300000023100

Created by admin on Sat Dec 16 16:41:02 GMT 2023 , Edited by admin on Sat Dec 16 16:41:02 GMT 2023

PRIMARY

INN

11883

Created by admin on Sat Dec 16 16:41:02 GMT 2023 , Edited by admin on Sat Dec 16 16:41:02 GMT 2023

PRIMARY

NCI_THESAURUS

C177084

Created by admin on Sat Dec 16 16:41:02 GMT 2023 , Edited by admin on Sat Dec 16 16:41:02 GMT 2023

PRIMARY

CAS

2444308-95-4

Created by admin on Sat Dec 16 16:41:02 GMT 2023 , Edited by admin on Sat Dec 16 16:41:02 GMT 2023

PRIMARY

WIKIPEDIA

Regdanvimab

Created by admin on Sat Dec 16 16:41:02 GMT 2023 , Edited by admin on Sat Dec 16 16:41:02 GMT 2023

PRIMARY

ACTIVE MOIETY


					I0BGE6P6I6